By rendering scientific advice, the Paul Ehrlich Institute helped the amoeba based vaccine to take its first big official hurdle in the first attempt. Since animal tests of Ciflu were positive and, in fact, superior in efficacy to the standard vaccine, the regulatory agency has authorized additional in vivo testing: A first official signal for the large potential of this new product.
Protection from bird flu possible
What is it, in fact, that makes Tetrahymena so much better than other vaccine production?
“I have been following research at Cilian AG very closely for years now“, explains Professor Tiedtke who is cell biologist and biotechnologist at the University of Münster in Germany. “Tetrahymena cells offer a lot of advantages. As eukaryotes, they possess similar features to human cells – meaning that compou ???????????????????????????????????????????????????????????????????????????????????????????????%?????????????????????????????????????????????????????????????????????????%?????????????L????????????????????????????????????????t???((0